Biotech stories
Kurraba Group secures SmartLabs, IWG and Thermo Fisher Scientific for its ION life sciences precinct, advancing the AUD $490 million Waterloo project.
i-GENTIC AI widens GENIE to spot FDA filing conflicts in real time, helping biopharma and medtech teams cut review delays.
OpenAI expands its enterprise AI push with a biology-focused model aimed at speeding target discovery, analysis and early drug development.
Kvantify names Dr David Siebert as global head of business development as it steps up commercial push for hybrid quantum-classical software.
US AI megadeals push global venture capital to a record USD $330.9 billion as OpenAI, Anthropic and xAI dominate first-quarter funding.
ACTO rolls out role-based AI SuperAgents for life sciences field teams, aiming to speed compliant access to approved content across sales and medical work.
Iran-linked wiper cyber attack cripples Stryker plants, disrupting implant production and locking thousands of staff out of global networks.
Biotech's next leaders will be defined less by scientific breakthroughs and more by diverse teams building resilient clinical infrastructure.
Belfast tech firm SciLeads will create 60 fully remote roles over three years as it scales its life sciences market intelligence platform.
MaRS says Canadian health tech faces a VC funding slump as China steps up, pressing Ottawa to improve procurement and scaling support.
BioOrbit wins GBP £9.8 million seed backing to scale orbital drug crystal production and push hospital-only medicines towards home use.
Canada's health tech leaders split over whether government should back global outcomes or build homegrown scale, as AI and procurement loom.
British Business Bank makes GBP £100 million first close commitment to Apposite Healthcare Growth I, aiming to fill the UK's life sciences scale-up gap.
Helical secures USD $10 million seed round to scale its AI-powered drug discovery platform across more pharma programmes.
Canada deepens life sciences push with CAD $127m for Vancouver projects as Aspect Biosystems and Providence Health Care expand biomanufacturing and trials.
British Business Bank adds GBP £10 million to Empirical Ventures to back deeptech 'venture scientists' and widen early-stage funding beyond London.
Expleo appoints Alan Gallagher to spearhead its life sciences expansion in Ireland, targeting pharma growth and digital modernisation.
Wilbe launches flexible life sciences lab hub in White City to tackle early-stage startup space crunch and back scientist founders.
CVCA: Canadian venture capital slid in 2025 even as private equity soared to CAD $57.5 billion, fuelled by a handful of mega-deals.
British Business Bank pledges up to GBP £50 million to IQ Capital Fund V, reinforcing a 20-year partnership backing UK deep tech.
